SB0205 codifies and expands Maryland’s health insurance mental health parity requirements by incorporating federal parity regulations into state law and clarifying the Maryland Insurance Administration’s enforcement authority. The bill applies to carriers offering health benefit plans, including insurers, HMOs, nonprofit health service plans, and other regulated entities, and it defines mental health benefits and substance use disorder benefits in a way that tracks current diagnostic standards and federal law. It also defines “core treatment” and uses that concept to evaluate whether benefits are meaningful across parity classifications.
The bill requires carriers to identify and analyze nonquantitative treatment limitations (such as prior authorization, network design, and other non-price restrictions), collect and evaluate data on how those limitations affect access to mental health, substance use disorder, and medical/surgical benefits, and provide comparative analyses to the Commissioner and, in some cases, to members. If data show material differences in access, that is treated as a strong indicator of noncompliance, and carriers must explain the differences and document corrective actions. The Commissioner is directed to review carrier reports, notify carriers of noncompliance, allow time for compliance plans and claim reprocessing, and then impose administrative orders or other penalties if needed. The bill also places the burden on carriers to prove compliance and directs the Commissioner to adopt implementing regulations.
In practical terms, SB0205 strengthens state oversight of mental health parity by making federal parity requirements enforceable through Maryland insurance law and by adding state-specific reporting, data collection, and enforcement mechanisms. It affects health insurers and other carriers by increasing documentation, analysis, and disclosure obligations, and it gives the Insurance Administration clearer authority to investigate and remedy parity violations. The bill takes effect July 1, 2026.
The overall sentiment around the bill appears strongly favorable. It passed the Senate unanimously and the House by a substantial margin, indicating broad bipartisan support for stronger mental health and substance use disorder coverage protections. The absence of recorded committee testimony in the provided materials suggests no major public controversy surfaced in the available record.
Any likely points of contention are technical rather than ideological. The bill imposes detailed compliance, reporting, and data-evaluation requirements on carriers, and it authorizes the Commissioner to treat certain access disparities as evidence of noncompliance. Insurers and carriers may be most affected by the added administrative burden, the expanded enforcement authority, and the requirement to demonstrate that their treatment limitations are not biased or more restrictive for behavioral health care than for medical/surgical care.
SB0205 amends Insurance Article § 15-144 to codify federal mental health parity requirements in Maryland law, expand definitions of mental health and substance use disorder benefits, require carrier data collection and comparative analyses of nonquantitative treatment limitations, and authorize the Maryland Insurance Commissioner to review, enforce, and penalize noncompliance. It also directs the Commissioner to adopt regulations establishing uniform definitions and methodologies for reporting, thereby increasing state oversight of health benefit plans and carrier parity practices.
The bill’s sentiment is broadly supportive and largely noncontroversial in the available record. It passed both chambers with strong margins, including a unanimous Senate vote, suggesting consensus around strengthening mental health and substance use disorder coverage protections and enforcement. No committee transcript opposition is provided, and the legislative history indicates a favorable reception overall.
The main points of contention are likely administrative and compliance-related rather than policy opposition to parity itself. Carriers may object to the bill’s expanded reporting, data collection, and documentation requirements, the Commissioner’s authority to treat material access differences as strong evidence of noncompliance, and the burden placed on carriers to prove that their nonquantitative treatment limitations comply with parity law. The bill also requires carriers to explain and correct access disparities, which could be seen as increasing regulatory scrutiny and operational costs.